Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Medicare

US government approves Alzheimer’s drug to slow cognitive decline

Some insurances, including the government-run Medicare, refused to pay for the drug until it received full approval.

Al Jazeera

Eisai Alzheimer's drug gets full US approval, widening access to the therapy

Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from U.S. regulators Thursday, a move expected to widen access to the first drug cleared based on its ability to slow progression of the mind-robbing disease.

Tribune News Service

Robodebt royal commission report handed down – as it happened

This blog is now closed.

The Guardian - AU

From analysis to the latest developments in health,
read the most diverse news in one place.

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it

U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease

The Independent UK

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

WEKU

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Roll Call

This Election Season, Beware of These False Promises

Many politicians offer a simplified view of the world—one in which government interventions are all benefits and no costs. That couldn't be further from the truth.

Reason

Read news from The Economist, FT, and more,
with one subscription

Expected Alzheimer’s drug approval signals new era in treatment - Roll Call

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

Roll Call

Why eating disorder treatments only work half the time, according to a psychologist

No single treatment will work for all people with eating disorders. Even the most highly researched evidence-based treatment may work for some people, but less so for others. When such treatments do not work, it can provoke anxiety.

The Conversation

Leaving Retirement? Three Things to Consider Before You Unretire

Some of today’s retirees are finding they’re withdrawing too much from their retirement accounts and need to return to work to make ends meet.

Kiplinger

Company's new wearable device will help diabetics eat right, lose weight

SAN DIEGO — San Diego's Dexcom, a maker of continuous glucose monitors, laid out plans for a new wearable device coming in 2024 for people with Type 2 diabetes who don't need insulin — a move that could help bring wearable health monitors closer to the mainstream.

Tribune News Service

Is Debating Debt Policy Actually Terrorism?

The fight over the debt ceiling has foreshadowed how the policy debates of the presidential election cycle are likely to go.

Reason

Does Medicare cover cataract surgery? What you need to know

The answer, like so much about Medicare, isn’t simple.

Fortune

Expensive dental care worsens inequality. Is it time for a Medicare-style 'Denticare' scheme?

There’s growing awareness public dental programs are unable to meet the demand for services. Private dental care is increasingly unaffordable, and millions of Australians go without the treatment they need.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

Zenger

Medicare To Negotiate Drug Prices, Lower Costs

CMS releases guidance on using authority to expand benefits, reduce drug costs, and strengthen Medicare program.

Newcastle Herald

The new changes rolling in with the new financial year from July 1

The Newcastle Herald has compiled a list of what you need to know.

Barchart

HSA vs. MSA: Which Health Savings Account is Right For You?

The Health Savings Account (HSA) and Medical Savings Account (MSA) can prove invaluable during your lifetime. But is one better than the other?

WEKU

78 people face charges for $2.5 billion in attempted health care fraud, DOJ says

At least $1.1 billion was actually paid out in these schemes targeting elderly patients, high-risk and low-income pregnant women and HIV patients.

Get all your
news in one place.

100’s of premium titles.
One news app.

Fortune

Insurers are bypassing hospitals and delivering pricey chemo and other infusion drugs via third-party pharmacies

As they lose out on billing for such drugs, hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."

The Guardian - US

Our primary healthcare system is a mess. We have a plan to fix it

Millions of Americans can’t access a doctor or dentist or have to wait months to be seen. Let’s change that

Tribune News Service

Editorial: Inflation Reduction Act will add to the deficit

Massive government spending programs typically cost more than projected. At some point, one might even call it a pattern.

Tribune News Service

Analysis: 10 memorable moments from six months of divided government

WASHINGTON — The 118th Congress has delivered on forecasts it would not send President Joe Biden much legislation to sign into law. It also has delivered on predictions of fireworks aplenty.

Roll Call

‘Shame!’: 10 memorable moments from six months of divided government

House Republican infighting has dominated the 118th Congress, and chaos — not legislation — is expected to flow for the rest of the year.

WEKU

Up First briefing: Russian rebellion; 'Cop City' protests; Alzheimer's drug approval

Yevgeny Prigozhin launched a failed rebellion in Russia. Activists in Atlanta hold a week of action against a police training facility. An Alzheimer's drug could be approved soon, but hurdles remain.

WEKU

An Alzheimer's drug is on the way, but getting it may still be tough. Here's why

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.

1 … 99 100 101 102

People

Marjorie Taylor Greene

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.